The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Saunders, Mark Henry, Dr
    Company Director born in September 1976
    Individual (2 offsprings)
    Officer
    2018-07-26 ~ now
    OF - director → CIF 0
    Dr Mark Henry Saunders
    Born in September 1976
    Individual (2 offsprings)
    Person with significant control
    2018-07-26 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

P2C PHARMA LTD

Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Turnover/Revenue
503,335 GBP2022-08-01 ~ 2023-07-31
415,078 GBP2021-08-01 ~ 2022-07-31
Raw materials and consumables used in the production process
0 GBP2022-08-01 ~ 2023-07-31
0 GBP2021-08-01 ~ 2022-07-31
Staff Costs/Employee Benefits Expense
-9,096 GBP2022-08-01 ~ 2023-07-31
-8,912 GBP2021-08-01 ~ 2022-07-31
Expenses related to depreciation, amortization, and impairment of assets
-180 GBP2022-08-01 ~ 2023-07-31
-180 GBP2021-08-01 ~ 2022-07-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
-85,635 GBP2022-08-01 ~ 2023-07-31
-72,912 GBP2021-08-01 ~ 2022-07-31
Profit/Loss
367,624 GBP2022-08-01 ~ 2023-07-31
310,840 GBP2021-08-01 ~ 2022-07-31
Called-up share capital not yet paid and not classified as a current asset
1 GBP2023-07-31
1 GBP2022-07-31
Fixed Assets
0 GBP2023-07-31
4,043 GBP2022-07-31
Current Assets
827,899 GBP2023-07-31
512,268 GBP2022-07-31
Creditors
Amounts falling due within one year
0 GBP2023-07-31
0 GBP2022-07-31
Net Current Assets/Liabilities
886,633 GBP2023-07-31
565,261 GBP2022-07-31
Total Assets Less Current Liabilities
886,634 GBP2023-07-31
569,305 GBP2022-07-31
Creditors
Amounts falling due after one year
0 GBP2023-07-31
0 GBP2022-07-31
Net Assets/Liabilities
788,126 GBP2023-07-31
480,322 GBP2022-07-31
Equity
788,126 GBP2023-07-31
480,322 GBP2022-07-31
Average Number of Employees
12022-08-01 ~ 2023-07-31

  • P2C PHARMA LTD
    Info
    Registered number 11485980
    Starcourt Thames Street, Sonning, Reading RG4 6UR
    Private Limited Company incorporated on 2018-07-26 (6 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2024-07-24
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.